Review of Asthma: Pathophysiology and Current Treatment Options

Clinical Pediatric Emergency Medicine

Volumn 8, Issue 2, 2007, Pages 87-95

  Linzer Sr , Jeffrey F ^a,b  

^a Children's Healthcare of Atlanta at Egleston ^*  (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

asthma; bronchodilators; corticosteroids

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE ACETATE; DEXAMETHASONE SODIUM PHOSPHATE; FLUNISOLIDE; HELIOX; IPRATROPIUM BROMIDE; KETAMINE; LEUKOTRIENE; LEVALBUTEROL; MAGNESIUM DERIVATIVE; MAGNESIUM HEPTAHYDRATE; MAGNESIUM SULFATE; MEPREDNISONE; METHYLPREDNISOLONE ACETATE; METHYLPREDNISOLONE SODIUM SUCCINATE; OXYGEN; PIRBUTEROL; PLACEBO; PREDNISOLONE; PREDNISONE; SALBUTAMOL; STEROID; TERBUTALINE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CHILD CARE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; DRUG DOSE TITRATION; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HUMAN; LOADING DRUG DOSE; MEDICAL DECISION MAKING; METERED DOSE INHALER; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; SINGLE DRUG DOSE; TACHYCARDIA; TH2 CELL; TREMOR; UNSPECIFIED SIDE EFFECT;

EID: 34447123943     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpem.2007.04.003     Document Type: Article

References (93)

1. Akinbami L. The state of childhood asthma, United States, 1980-2005. Advance data from vital and health statistics; no 381 (2006), National Center for Health Statistics, Hyattsville (MD)
2. Busse W.W., O'Bryne P.M., and Holgate S.T. Asthma pathogenesis. In: Adkinson Jr. N.F., Yunginger J.W., Busse W.W., et al. (Eds). Adkinson: Middleton's allergy: principles and practice. 6th ed. (2006), CV Mosby, Philadelphia [Chapter 66]
3. Durham S.R., Till S.J., and Corrigan C.J. T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol 106 (2000) 221-226
4. Holgate S.T., Davies D.E., Lackie P.M., et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 105 (2000) 193-204
5. Bradding P., Freezer N.J., Sheffer A.L., et al. Asthma. In: Frank M.M., Austen K.F., Claman H.N., et al. (Eds). Samter's immunologic diseases. 5th ed. (1995), Little, Brown and Company, Boston 1293-1327
6. Lagerstrand L., Bylin G., Hedenstierna G., et al. Relationships among gas exchange, spirometry and symptoms in asthma. Eur J Med 1 (1992) 145-152
7. National Heart, Lung, and Blood Institute, and National Institutes of Health. Expert panel report 2: guidelines for the diagnosis and management of asthma (1997) NIH Publication No. 97-4051, Bethesda, MD
8. Ferrer A., Roca J., Wagner P.D., et al. Airway obstruction and ventilation-perfusion relationships in acute severe asthma. Am Rev Respir Dis 147 (1993) 579-584
9. Ben-Ziv Z., Lam C., Hoffman J., et al. An evaluation of the initial treatment of acute asthma. Pediatrics 70 (1982) 348-353
10. Becker A.B., Nelson N.A., and Simons F.E.R. Inhaled salbutamol vs. injected epinephrine in the treatment of acute asthma in children. J Pediatr 102 (1983) 465-469
11. Louridas G., Kakoura M., Galanis N., et al. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma. Respiration 44 (1983) 439-443
12. Travers A., Jones A.P., Kelly K., et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev (2001) 10.1002/14651858.CD002988 Art. No.: CD002988
13. Putland M., Kerr D., and Kelly A.M. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 47 (2006) 559-563
14. Plint A.C., Osmond M.H., and Klassen T.P. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 7 (2000) 1097-1103
15. Nelson H.S., Spector S.L., Whitsett T.L., et al. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol 72 (1983) 371-375
16. Schuh S., Parkin P., Rajan A., et al. High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 83 (1989) 513-518
17. National Heart, Lung, and Blood Institute, and National Institutes of Health. Expert panel report: guidelines for the diagnosis and management of asthma-update on selected topics 2002 (2003) NIH Publication No. 02-5074, Bethesda, MD
18. Nelson H.S., Bensch G., Pleskow W.W., et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 102 (1998) 943-952
19. Gawchik S.M., Saccar C.L., Noonan M., et al. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 103 (1999) 615-621
20. Carl J.C., Myers T.R., Kirchner H.L., et al. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr 143 (2003) 731-736
21. Hardasmalani M.D., DeBari V., Bithoney W.G., et al. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care 21 (2005) 415-419
22. Qureshi F., Zaritsky A., Welch C., et al. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 46 (2005) 29-36
23. Nowak R., Emerman C., Hanrahan J.P., et al. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med 24 (2006) 259-267
24. Abbott M.B., Levin R.H., and Miller J.A. Question from the clinician: levalbuterol in managing pediatric asthma. Pediatr Rev 23 (2002) 401-403
25. Plotnick L.H., and Ducharme F.M. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev (2000) 10.1002/14651858.CD000060 Art. No.: CD000060
26. Rodrigo G.J., and Castro-Rodriguez J.A. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with metaanalysis. Thorax 60 (2005) 740-746
27. Qureshi F., Zaritsky A., and Lakkis H. Efficacy of nebulized ipratropium in severely asthmatic children. Ann Emerg Med 29 (1997) 205-211
28. Cates C.J., Crilly J.A., and Rowe B.H. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev (2006) 10.1002/14651858.CD000052.pub2 Art. No.: CD000052
29. Chou K.J., Cunningham S.J., and Crain E.F. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 149 (1995) 201-205
30. Delgado A., Chou K.J., Silver E.J., et al. Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med 157 (2003) 76-80
31. Camargo Jr. C.A., Spooner C.H., and Rowe B.H. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev (2003) 10.1002/14651858.CD001115 Art. No.: CD001115
32. Dolovich M.B., Ahrens R.C., Hess D.R., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127 (2005) 335-371
33. Deerojanawong J., Manuyakorn W., Prapphal N., et al. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 39 (2005) 466-472
34. Papo M.C., Frank J., and Thompson A.E. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 21 (1993) 1479-1486
35. Khine H., Fuchs S.M., and Saville A.L. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med 3 (1996) 1019-1024
36. Frei S.P. Cost comparison of bronchodilator delivery methods in emergency department treatment of asthma. J Emerg Med 19 (2000) 323-326
37. Leversha A.M., Campanella S.G., Aickin R.P., et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr 136 (2000) 497-502
38. Linzer J.F., Vance C., and Letourneau M. Safety of continuously nebulized undiluted albuterol in children with severe acute asthma (abstract). Ped Emerg Care 12 (1996) 328
39. Rowe B.H., Spooner C., Ducharme F.M., et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev (2001) 10.1002/14651858.CD002178 Art. No.: CD002178
40. Rowe B.H., Spooner C.H., Ducharme F.M., et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev (2001) 10.1002/14651858.CD000195 Art. No.: CD000195
41. Scarfone R.J., Fuchs S.M., Nager A.L., et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 92 (1993) 513-518
42. Barnett P.J.L., Caputo G.L., Baskin M., et al. Intravenous vs. oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 29 (1997) 212-217
43. Becker J.M., Arora A., Scarfone R.J., et al. Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol 103 (1999) 586-590
44. Klig J.E., Hodge D., and Rutherford M.W. Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. J Asthma 34 (1997) 419-425
45. Gries D.M., Moffitt D.R., Pulos E., et al. A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr 136 (2000) 298-303
46. Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J Pediatr 142 (2003) S40-S44
47. Storr J., Barrell E., Barry W., et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1 (1987) 879-882
48. Ellul-Micallef R., and French F.F. Effect of intravenous prednisolone in patients with diminished adrenergic responsiveness. Lancet 2 (1975) 1269-1271
49. McNamara R.M., and Rubin J.M. Intramuscular methylprednisolone acetate for the prevention or relapse in acute asthma. Ann Emerg Med 22 (1993) 1829-1835
50. Lahn M., Bijur P., and Gallagher E.J. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 126 (2004) 362-368
51. Qureshi F., Zaritsky A., and Poirier M.P. Comparative efficacy or oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr 139 (2001) 20-26
52. Sung L., Osmond M.H., and Klassen T.P. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emerg Med 5 (1998) 209-213
53. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med 101 (2006) 685-695
54. Chipps B.E., and Chipps D.R. A review of the role of inhaled corticosteroids in the treatment of acute asthma. Clin Pediatr 40 (2001) 185-189
55. Edmonds M.L., Camargo C.A., Pollack C.V., et al. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med 40 (2002) 145-154
56. Tsai Y.G., Lee M.Y., Yang K.D., et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 139 (2001) 433-437
57. Devidayal, Singhi S., Kumar L., et al. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 88 (1999) 835-840
58. Volovitz B., Bentur L., Finkelstein Y., et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 102 (1998) 605-609
59. Schuh S., Reisman J., Alshehri M., et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 343 (2000) 689-694
60. Ververeli K., and Chipps B. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. Ann Allergy Asthma Immun 92 (2004) 512-522
61. Singhi S.C., Banerjee S., and Nanjundaswamy H.M. Inhaled budesonide in acute asthma. J Pediatr Child Health 35 (1999) 483-487
62. Nakanishi A.K., Klasner A.K., and Rubin B.K. A randomized control trial of inhaled flunisolide in the management of acute asthma in children. Chest 124 (2003) 790-794
63. Rodrigo G., and Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 157 (1998) 698-703
64. Spivey W.H., Skobeloff E.M., and Levin R.M. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med 19 (1990) 1107-1112
65. Lindeman K.S., Hirshman C.A., and Freed A.N. Effect of magnesium sulfate on bronchoconstriction in the lung periphery. J Appl Physiol 66 (1989) 2527-2532
66. Rowe B.H., Bretzlaff J.A., Bourdon C., et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev (2000) 10.1002/14651858.CD004490 Art. No.: CD001490
67. Blitz M., Blitz S., Beasely R., et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev (2005) 10.1002/14651858.CD008898.pub4 Art. No.: CD003898
68. Ciarallo L., Brousseau D., and Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 154 (2000) 979-983
69. Blitz M., Blitz S., Hughes R., et al. Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest 128 (2005) 337-344
70. Shirk M.B., Donahue K.R., and Shirvani J. Unlabeled uses of nebulized medications. Am J Health Syst Pharm 63 (2006) 1704-1716
71. Mahajan P., Haritos D., Rosenberg N., et al. Comparison of nebulized magnesium plus albuterol to nebulized albuterol plus saline in children with mild to moderate asthma. J Emerg Med 27 (2004) 21-25
72. Papamoschou D. Theoretical validation of the respiratory benefits of helium-oxygen mixtures. Respir Physiol 99 (1995) 183-190
73. Anderson M., Svartengren M., Bylin G., et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis 147 (1993) 524-528
74. Hess D.R., Acosta F.I., Ritz R.H., et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 115 (1999) 184-189
75. Rodrigo G., Pollack C., Rodrigo C., et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev (2006) 10.1002/14651858.CD002884.pub2 Art. No.: CD002884
76. Kim I.K., Phrampus E., Venkataraman S., et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 116 (2005) 1127-1133
77. Kudukis T.M., Manthous C.A., Schmidt G.A., et al. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr 130 (1997) 217-224
78. Sarma V.J. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand 36 (1992) 106-107
79. Strube P.J., and Hallam P.L. Ketamine by continuous infusion in status asthmaticus. Anaesthesia 40 (1986) 1017-1019
80. Howton J.C., Rose J., Duffy S., et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 27 (1996) 170-175
81. Denmark T.K., Crane H.A., and Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med 30 (2006) 163-166
82. Petrillo T.M., Fortenberry J.D., Linzer J.F., et al. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 38 (2001) 657-664
83. Allen J.Y., and Macias C.G. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 46 (2005) 43-50
84. Mitra A., Bassler D., Watts K., et al. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev (2005) 10.1002/14651858.CD001276.pub2 Art. No.: CD001276
85. Harmanci K., Bakirtas A., Turktas I., et al. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol 96 (2006) 731-735
86. Silverman R.A., Nowak R.M., Korenblat P.E., et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 126 (2004) 1480-1489
87. Fortenberry J.D., Del Toro J., Jefferson L.S., et al. Management of pediatric acute hypoxemic respiratory insufficiency with bilevel positive pressure (BiPAP) nasal mask ventilation. Chest 108 (1995) 1059-1064
88. Ram F.S.F., Wellington S.R., Rowe B., et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev (2005) 10.1002/14651858.CD004360.pub3 Art. No.: CD004360
89. Beers S.L., Abramo T.J., Bracken A., et al. Bilevel positive airway pressure in the treatment of status asthmaticus in pediatrics. Am J Emerg Med 25 (2007) 6-9
90. Graham V., Lasserson T.J., and Rowe B.H. Antibiotics for acute asthma. Cochrane Database Syst Rev (2001) 10.1002/14651858.CD002941 Art. No.: CD002741
91. Boychuk R.B., Yamamoto L.G., DeMesa C.J., et al. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization. Am J Emerg Med 24 (2006) 48-52
92. Rowe B.H., Bota G.W., Fabris L., et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 281 (1999) 2119-2126
93. Sin D.D., and Man S.F. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 162 (2002) 1591-1595